Skip to main content
. 2017 Nov 1;17(Suppl 1):706. doi: 10.1186/s12879-017-2768-z

Fig. 3.

Fig. 3

Proportion of patients on tenofovir-based regimens, by year and HBsAg status in ten sub-Saharan African countries, 2010–2012. Others: HbsAg-negative or not screened